Detailed View
CGON - CG Oncology, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
6,484,645,376
Adj EBIT (TTM)
-214,959,000
Enterprise Value
5,411,403,376
Last Price
73.52
Earnings Yield
-3.97%
Return on Capital
-19.74%
Capital
1,089,189,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 1,083,000 | -66,389,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 2,322,000 | -48,700,000 |
| 2025-09-30 | 10-Q | 2025 | 1,666,000 | -51,129,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -48,741,000 |
| 2025-03-31 | 10-Q | 2025 | 52,000 | -42,204,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 456,000 | -38,049,000 |
| 2024-09-30 | 10-Q | 2024 | 43,000 | -28,295,000 |
| 2024-06-30 | 10-Q | 2024 | 111,000 | -25,853,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.